AKT1 and prostate carcinoma: Additionally, the knockdown mutation of ATF3 promotes the development of prostate cancer through activation of PI3K/Akt signaling [40], which is crucial for the growth, survival, and development of prostate cancer cells [41] and suggests that ATF3 is a promising cancer preventive-therapeutic target.